Alicia Hulbert,MD

[Jony Arroyo 🇪🇸 @jonyarroyo]

Nueva York: ¡HEMOS VUELTO!

¡A la final! 🇪🇸

[Alicia Hulbert,MD @HulbertAlicia]

Grateful to have led this project with an amazing team. Our study identifies CEACAM7 as a novel biomarker in African Americans with LUAD, linking methylation & expression to survival outcomes. A step forward for precision oncology & health equity.

[UICscience @UICscience]

@thisisUIC researchers found the gene CEACAM7 may be associated with mortality risk and survival times from a type of lung cancer called lung adenocarcinoma in African Americans.

The finding is a step forward in personalized oncology and health equity.

📗https://t.co/KKDUC1yI6o

[UICscience @UICscience]

@thisisUIC researchers found the gene CEACAM7 may be associated with mortality risk and survival times from a type of lung cancer called lung adenocarcinoma in African Americans.

The finding is a step forward in personalized oncology and health equity.

📗https://t.co/KKDUC1yI6o

[Ignacio Jusué-Torres MD FAANS FCNS FEBNS @JusueMD]

Landmark paper discussing the need for serial longitudinal tissue sampling to have an impact on molecular changes over time on #glioblastoma #btsm @naturemedicine @NeuroOnc @IanParneyMDPhD @MayoClinic @MayoClinicNeuro

[Bernard Bendok, MD @BernardBendokMD]

Important message from WFNS President Dr. Nelson Oyesiku.

[gilberto lopes @GlopesMd]

I’m his own words - @ASCOPres Lessons learned - @asco #asco23

[Amina Chaudhry @AminaChaudhryMD]

#ASCO2023 Important work by our very own @KKennedyMD looking at the impact of neighborhood deprivation and epigenetic changes on lung cancer survival. Proud to have her as a friend and colleague dedicated to improving lung cancer outcomes for all. @UICHemOnc @UICancerCenter

[Ignacio Jusué-Torres MD FAANS FCNS FEBNS @JusueMD]

Very happy to share our recent publication with Dr @HulbertAlicia on #epigenetic #DNAmethylation #liquidbiopsy #lungcancer #survival #predictor published with @SpringerNature in @SciReports https://t.co/UjZv6tewoQ

[Alicia Hulbert,MD @HulbertAlicia]

Wonderful presentation last week for Mayo Clinic Neurosurgery and Neuroscience Virtual Grand Rounds by my talented husband @JusueMD @mayoclinicneuro @BernardBendokMD

[Bernard Bendok, MD @BernardBendokMD]

This Friday at 10AM EST: Mayo Clinic Neurosurgery and Neuroscience Virtual Grand Rounds featuring Dr. Ignacio Jusue-Torres: “Expanding the Boundaries on Outcomes for Brain Tumors and Normal Pressure Hydrocephalus”. To attend: https://t.co/BbMawpsxqA #MayoClinic

[Ignacio Jusué-Torres MD FAANS FCNS FEBNS @JusueMD]

Great graphical summary about one of the landmark papers in current #glioma management @NeurosurgeryCNS https://t.co/8np4U0hZBN @CNS_Update

[Alicia Hulbert,MD @HulbertAlicia]

I want to wish everyone a Happy thanksgiving! hope everyone is able to spend the day with friends and family. Cheers to the rest of 2021 and excited to see where science brings us in 2022!

[Elsa Anagnostou @ValsamoA]

Here's the newest from @HopkinsThoracic:
👉 #cfDNA fragmentation & #lungcancer detection @NatureComms
https://t.co/UyKaBR4H4Q
👉Single-cell MANA-reactive TIL profiles @nature
https://t.co/EPmqkn3at1
👉Clinical & genomic analyses of PrE0505 @NatureMedicine
https://t.co/e2MT8Gbqhh

[Foteinos-Ioannis Dimitrakopoulos @fodimitrak]

Just out in @Cancers_MDPI our study on the "Clinical Significance of CD9+ Plasma Exosomes in HIV+/- #lungcancer Pts" https://t.co/YiVawFQrvx. Many 🙏 to Prof. M. Brock, @HulbertAlicia, Prof. St. Baylin, @SteveYangMD, @JulieBrahmer, Dr. A. Kottorou and all contributors.

[Charlie Rudin @charlesrudin]

https://t.co/e2EIBThkWc Out today - the single-cell atlas of human small cell lung cancer, a collaborative effort co-directed by the amazing @dana_peer with heavy lifting by first authors @jmchan88 @AlvaroQuintanal @GaoVianne and @Yubin_Xie. An @sloan_kettering dream team. #LCSM

[Maciej Lesniak, MD @maciejlesniakmd]

Best advice one can give anyone

[Ignacio Jusué-Torres MD FAANS FCNS FEBNS @JusueMD]

Honored to be featured as editor’s choice by @WorldNeurosurg on our recent study on #socioeconomic #disparities in #NSCLC with brain #metastases at presentation

[Ignacio Jusué-Torres MD FAANS FCNS FEBNS @JusueMD]

Our paper “Socio-economic disparities in non-small-cell lung cancer with brain metastases at presentation: a population-based study” was recognized as Editor’s choice on @WorldNeurosurg @hulbertalicia

https://t.co/0SpP9cLsJQ

https://t.co/nTcWPNvue5

[Stephen V Liu, MD @StephenVLiu]

#WCLC21 The barrier to cfDNA has been cost - but we have to consider what happens next. Missing a biomarker means delivering less effective therapy, usually chemo-immunotherapy which has its own costs. This analysis shows liquid biopsy led to cost SAVINGS of $37,216 per patient.